Importance of sentinel lymph node biopsy in patients with thin melanoma

Archives of Surgery

Volumn 143, Issue 9, 2008, Pages 892-899

  Wright, Byron E ^a   Scheri, Randall P ^a   Ye, Xing ^a   Faries, Mark D ^a   Turner, Roderick R ^a   Essner, Richard ^a   Morton, Donald L ^a  

^a JOHN WAYNE CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY; THIN MELANOMA; TUMOR VOLUME;

ADULT; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS;

EID: 52249114520     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.143.9.892     Document Type: Article

References (37)

1. Morton DL, Thompson JF, Cochran AJ, et al; MSLT Group. Sentinel-node biopsy or nodal observation in melanoma [published correction appears In N Engl J Med. 2006;355(18):1944]. N Engl J Med. 2006;355(13):1307-1317.
2. Sondak VK, Zager JS, Messina JL, Thomas JM. Sentinel lymph node biopsy as the standard of care for cutaneous melanoma. Clin Adv Hematol Oncol. 2007; 5(6):483-490.
3. Morton DL, Thompson JF, Essner R, et al. Validation of the accuracy of intraop-erative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma. Ann Surg. 1999;230(4):453-465.
4. Morton DL, Cochran AJ, Thompson JF, et al; Multicenter Selective Lymphadenectomy Trial Group. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity In MSLT-1,an international muIticenter trial. Ann Surg. 2005; 242(3):302-311.
5. Balch CM, Soong SJ, Bartolucci AA, et al. Efficacy of an elective regional lymph node dissection of 1-4 mm thick melanomas for patients 60 years of age and younger. Ann Surg. 1996;224(3):255-266.
6. Balch CM, Soong SJ, Ross Ml, et al; Investigators From the Intergroup Melanoma Surgical Trial. Long-term results of a multi-institutional randomized trial comparing prognosticfactors and surgical results for Intermediate thickness melanomas (1.0 to 4.0 mm). Ann Surg Oncol. 2000;7(2):87-97.
7. McKinnon JG, Yu XQ, McCarthy WH, Thompson JF. Prognosis for patients with thin cutaneous melanoma: long-term survival data from the New South Wales Central Cancer Registry and the Sydney Melanoma Unit. Cancer. 2003;98(6): 1223-1231.
8. Kalady MF, White RR, Johnson JL, Tyler DS, Seigler HF. Thin melanomas: predictive lethal characteristics from a 30-year clinical experience. Ann Surg. 2003; 238(4):528-535.
9. Bleicher RJ, Essner R, Foshag LJ, Wanek LA, Morton DL. Role of sentinel lymphadenectomy In thin invasive cutaneous melanomas. J Clin Oncol. 2003;21(7): 1326-1331.
10. Stitzenberg KB, Groben PA, Stern SL, et al. Indications for lymphatic mapping and sentinel lymphadenectomy In patients with thin melanoma (Breslow thickness < or= 1.0 mm). Ann Surg Oncol. 2004;11(10);900-906.
11. Karakousis GC, Gimotty PA, Czerniecki BJ, et al. Regional nodal metastatic disease is the strongest predictor of survival in patients with thin vertical growth phase melanomas: a case for SLN staging biopsy in these patients. Ann Surg Oncol. 2007;14(5):1596-1603.
12. Karakousis GC, Gimotty PA, Botbyl JD, et al. Predictors of regional nodal disease in patients with thin melanoma. Ann Surg Oncol. 2006;13(4):533-541.
13. Wong SL, Brady MS, Busam KJ, Coit DG. Results of sentinel lymph node biopsy in patients with thin melanoma. Ann Surg Oncol. 2006;13(3):302-309.
14. Greene FL, Page DL, Fleming ID, et al, eds. AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer; 2002.
15. National Cancer Care Network. Clinical Practice Guidelines in Oncology: Melanoma: v.1.2008. http://www.nccn.org. Accessed March 6, 2008.
16. Ranieri JM, Wagner JD, Wenck S, Johnson CS, Coleman JJ III. The prognostic importance of sentinel lymph node biopsy in thin melanoma. Ann Surg Oncol. 2006;13(7):927-932.
17. Jacobs IA, Chang CK, Das GuptaTK, Salti Gl. Role of sentinel lymph node biopsy in patients with thin (<1 mm) primary melanoma. Ann Surg Oncol. 2003;10 (5):558-561.
18. Essner R. Surgical treatment of malignant melanoma. Surg Clin North Am. 2003; 83(1):109-156.
19. Turner RR, Weaver DL, Cserni G, et al. Nodal stage classification for breast carcinoma: improving interobserver reproducibility through standardized histo-logic criteria and image-based training. J Clin Oncol. 2008;26(2):258-263.
20. Reintgen DS, Jakub JW, Pendas S, Swor G, Giuliano R, Shivers S. The staging of malignant melanoma and the Florida Melanoma Trial. Ann Surg Oncol. 2004; 11(3)(suppl):186S-191S.
21. Leong SP. Sentinel lymph node mapping and selective lymphadenectomy: the standard of care for melanoma. Curr Treat Options Oncol. 2004:5(3):185-194.
22. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127(4):392-399.
23. Wasserberg N, Tulchinsky H, Schachter J, Feinmesser M, Gutman H. Sentinel lymph node biopsy (SLNB) for melanoma Is not complication-free. Eur J Surg Oncol. 2004;30(8):851-856 .
24. Harris MN, Roses DF, Culliford AT, Gumport SL. Melanoma of the head and neck. Ann Surg. 1975;182(1 ):86-91.
25. Fortner JG, Woodruff J, Schottenfeld D, Maclean B. Biostatistical basis for elective node dissection for malignant melanoma. Ann Surg. 1977;186(1 ):101-103.
26. Gupta TK. Results of treatment of 269 patients with primary cutaneous melanoma: a five-year prospective study. Ann Surg. 1977:186(2):201-209.
27. Veronesi U, Adamus J, Bandiera DC, et al. Inefficacy of immediate node dissection in stage 1 melanoma of the limbs. N EnglJ Med. 1977;297(12):627-630.
28. Veronesi U, Adamus J, Bandiera DC, et al. Delayed regional lymph node dissection In stage I melanoma of the skin of the lower extremities. Cancer. 1982; 49(11):2420-2430.
29. Sim FH, Taylor WF, Ivins JC, Pritchard DJ, Soule EH. A prospective randomized study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma: preliminary results. Cancer. 1978;41(3):948-956.
30. Jemal A, Siegel R, Ward E, MurrayT, Xu J, Thun MJ. Cancerstatistics, 2007. CA Cancer JCIin. 2007;57(1):43-66.
31. Ra JH, McMasters KM, Spitz FR. Should all melanoma patients undergo sentinel lymph node biopsy? CurrOpin Oncol. 2006;18(2)185-188.
32. Gimotty PA. Guerry D. Ming ME. et al. Thin primary cutaneous malignant melanoma: a prognostic tree for 10-year metastasis Is more accurate than American Joint Committee on Cancer Staging [published correction appears In J Clin Oncol. 2005;23(3):656]. JCIin Oncol. 2004;22(18):3668-3676.
33. Oliveira Filho RS, Ferreira LM, Biasi LJ, Enokihara MM, Paiva GR, Wagner J. Vertical growth phase and positive sentinel node In thin melanoma. BrazJ Med Biol Res. 2003;36(3):347-350.
34. Cecchi R, Buralli L, Innocenti S, De Gaudio C. Sentinel lymph node biopsy In patients with thin melanomas. J Dermatol. 2007;34(8):512-515.
35. Hershko DD, Robb BW, Lowy AM, et al. Sentinel lymph node biopsy In thin melanoma patients. J Surg Oncol. 2006;93(4):279-285.
36. Kesmodel SB. Karakousis GC. Botbyl JD, et al. Mitotic rate as a predictor of sentinel lymph node positivity In patients with thin melanomas. Ann Surg Oncol. 2005; 12(6):449-458.
37. Lowe JB, Hurst E, Moley JF, Cornelius LA. Sentinel lymph node biopsy In patients with thin melanoma. Arch Dermatol. 2003;139(5):617-621.